The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of HDAC inhibitor tucidinostat in combination with anti-PD-1 antibody in patients with locally advanced or metastatic urothelial carcinoma.
 
Zhuowei Liu
No Relationships to Disclose
 
Lijuan Jiang
No Relationships to Disclose
 
Xiangdong Li
No Relationships to Disclose
 
Yunlin Ye
No Relationships to Disclose
 
Zhiming Wu
No Relationships to Disclose
 
Xin An
No Relationships to Disclose
 
Yanxia Shi
No Relationships to Disclose
 
Kai Yao
No Relationships to Disclose